Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Clifford Greyson

Concepts (170)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ventricular Dysfunction, Right
4
2010
231
0.760
Why?
Ventricular Function, Right
3
2011
276
0.690
Why?
Calpain
2
2012
57
0.670
Why?
Heart Failure
5
2012
2150
0.590
Why?
Myocardial Contraction
7
2013
335
0.570
Why?
Myocardial Reperfusion Injury
5
2013
129
0.520
Why?
Swine
20
2017
760
0.430
Why?
Hypertension, Pulmonary
4
2012
1894
0.420
Why?
Pulmonary Heart Disease
1
2012
6
0.410
Why?
Heart Ventricles
7
2012
781
0.400
Why?
Talin
1
2012
8
0.400
Why?
Hemodynamics
11
2012
1090
0.390
Why?
Cardiotonic Agents
4
2008
126
0.380
Why?
Pulmonary Circulation
2
2012
430
0.370
Why?
Adenosine Triphosphate
5
2017
480
0.330
Why?
Adenosine Diphosphate
2
2008
80
0.310
Why?
Coronary Occlusion
1
2008
18
0.310
Why?
Ventricular Fibrillation
3
2017
57
0.300
Why?
Prodrugs
1
2008
48
0.300
Why?
Ventricular Function
2
2008
61
0.290
Why?
Ventricular Pressure
1
2007
44
0.290
Why?
Intensive Care Units
1
2012
738
0.280
Why?
Folic Acid
1
2008
184
0.280
Why?
Myocardial Ischemia
5
2017
258
0.250
Why?
Heart
6
2009
637
0.250
Why?
Acute Disease
4
2012
980
0.250
Why?
Metabolic Syndrome
3
2013
339
0.220
Why?
Thiazolidinediones
4
2012
137
0.220
Why?
PPAR gamma
3
2012
183
0.200
Why?
Cardiac Output
2
2012
156
0.180
Why?
Dipeptides
2
2012
49
0.170
Why?
Animals
24
2017
35361
0.150
Why?
Swine, Miniature
3
2013
81
0.150
Why?
Energy Metabolism
5
2004
874
0.140
Why?
Coronary Circulation
7
2004
138
0.140
Why?
Myocardium
8
2004
980
0.140
Why?
Systole
4
2001
191
0.120
Why?
Disease Models, Animal
8
2013
4063
0.120
Why?
Heart Function Tests
2
2013
59
0.120
Why?
Dobutamine
3
2000
37
0.110
Why?
Metformin
1
2017
315
0.100
Why?
Insulin Resistance
2
2013
1165
0.100
Why?
Actinin
1
2012
13
0.100
Why?
Nitric Oxide Synthase Type III
2
2013
203
0.100
Why?
Diastole
3
2001
148
0.100
Why?
Uncertainty
1
2012
116
0.090
Why?
Electrophoresis, Polyacrylamide Gel
1
2012
330
0.090
Why?
Dietary Fats
2
2013
301
0.090
Why?
Central Venous Pressure
1
2011
14
0.090
Why?
Radionuclide Imaging
1
2011
123
0.090
Why?
Hypertension
1
2000
1242
0.090
Why?
Reperfusion Injury
2
2005
272
0.090
Why?
Molecular Targeted Therapy
1
2012
390
0.080
Why?
Ischemia
1
2012
406
0.080
Why?
Premedication
1
2008
42
0.080
Why?
Hyperhomocysteinemia
1
2008
27
0.080
Why?
Radiography
1
2011
798
0.080
Why?
Nitric Oxide Synthase Type II
1
2008
171
0.070
Why?
Obesity
2
2013
2883
0.070
Why?
Drug Evaluation, Preclinical
1
2008
171
0.070
Why?
KATP Channels
1
2008
20
0.070
Why?
Densitometry
1
2007
34
0.070
Why?
Spectrin
1
2007
14
0.070
Why?
Desmin
1
2007
24
0.070
Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
1
2007
37
0.070
Why?
Insulin
3
2013
2326
0.070
Why?
Troponin
1
2007
50
0.070
Why?
Purines
1
2008
172
0.070
Why?
Ultrasonography
1
2011
716
0.070
Why?
Rats, Wistar
1
2008
441
0.070
Why?
Hypoglycemic Agents
3
2012
1220
0.070
Why?
Heart-Assist Devices
1
2012
539
0.060
Why?
Calcium-Binding Proteins
1
2007
210
0.060
Why?
Phosphocreatine
3
1994
43
0.060
Why?
Fenofibrate
1
2005
31
0.060
Why?
Fetus
1
2010
773
0.060
Why?
Protein Processing, Post-Translational
1
2007
455
0.060
Why?
Oxygen Consumption
4
1996
672
0.060
Why?
Blood Pressure
4
2009
1736
0.060
Why?
Ventricular Function, Left
4
2004
527
0.050
Why?
Nitric Oxide
1
2008
902
0.050
Why?
Female
15
2017
68776
0.050
Why?
Phosphorylation
3
2013
1713
0.050
Why?
Glucose
3
2013
1003
0.050
Why?
Prognosis
1
2011
3794
0.050
Why?
Endothelium, Vascular
1
2008
901
0.050
Why?
Oxidative Stress
1
2008
1269
0.050
Why?
Humans
6
2012
129650
0.050
Why?
Fatty Acids, Nonesterified
3
2004
160
0.050
Why?
Insulin Receptor Substrate Proteins
2
2013
59
0.050
Why?
Diacetyl
1
2001
6
0.050
Why?
Receptors, Cytoplasmic and Nuclear
1
2003
217
0.050
Why?
Myocardial Infarction
1
2008
1022
0.050
Why?
Apoptosis
1
2010
2503
0.050
Why?
Cytokines
2
2005
2017
0.040
Why?
Hexamethonium
1
2000
4
0.040
Why?
Atropine
1
2000
24
0.040
Why?
Dilatation, Pathologic
1
2000
60
0.040
Why?
Cardiovascular Diseases
1
2012
2004
0.040
Why?
Pericardium
1
2000
54
0.040
Why?
Rats
1
2008
5500
0.040
Why?
Potassium
1
2000
143
0.040
Why?
Proto-Oncogene Proteins c-akt
2
2013
431
0.040
Why?
Cardiovascular Agents
1
2000
156
0.040
Why?
Infant, Newborn
1
2010
5762
0.040
Why?
Magnetic Resonance Spectroscopy
3
1995
539
0.040
Why?
Linear Models
1
2000
819
0.040
Why?
Citrate (si)-Synthase
1
2017
57
0.030
Why?
Cardiac Catheterization
1
2000
518
0.030
Why?
Administration, Intravenous
1
2017
141
0.030
Why?
Male
7
2017
63681
0.030
Why?
Signal Transduction
1
2009
4925
0.030
Why?
AMP-Activated Protein Kinases
1
2017
191
0.030
Why?
Diet
2
2013
1213
0.030
Why?
Transcription Factors
1
2003
1651
0.030
Why?
Phosphorus
1
1995
93
0.030
Why?
Electric Stimulation
1
1995
269
0.030
Why?
Chromans
2
2004
24
0.030
Why?
Pulmonary Artery
1
2000
1096
0.030
Why?
Stroke Volume
1
1997
592
0.030
Why?
Acyl Coenzyme A
1
2013
30
0.030
Why?
Hydroxy Acids
1
2012
4
0.020
Why?
Decanoic Acids
1
2012
8
0.020
Why?
Ischemic Preconditioning, Myocardial
1
2012
30
0.020
Why?
Cardiolipins
1
2013
84
0.020
Why?
Potassium Channel Blockers
1
2012
36
0.020
Why?
Glyburide
1
2012
35
0.020
Why?
Anti-Arrhythmia Agents
1
2012
111
0.020
Why?
Blood Glucose
2
2013
2097
0.020
Why?
Biopsy
1
1995
1097
0.020
Why?
Arteries
1
2013
265
0.020
Why?
Cholesterol
1
2013
412
0.020
Why?
Death, Sudden, Cardiac
1
2012
179
0.020
Why?
MAP Kinase Signaling System
1
2013
312
0.020
Why?
Coronary Vessels
1
2012
241
0.020
Why?
Vasodilation
1
2013
476
0.020
Why?
Adiponectin
1
2009
235
0.020
Why?
Phosphatidylinositol 3-Kinases
1
2009
359
0.020
Why?
Adult
1
2010
35576
0.020
Why?
Time Factors
1
1997
6556
0.020
Why?
RNA, Messenger
2
2004
2708
0.020
Why?
PPAR alpha
1
2005
58
0.020
Why?
Hypolipidemic Agents
1
2005
92
0.010
Why?
Heart Rate
2
2001
802
0.010
Why?
Sus scrofa
1
2004
46
0.010
Why?
alpha-Tocopherol
1
2004
33
0.010
Why?
Isoproterenol
2
1994
115
0.010
Why?
Thiazoles
1
2003
117
0.010
Why?
Verapamil
1
2001
41
0.010
Why?
Antioxidants
1
2004
559
0.010
Why?
Organ Preservation Solutions
1
2001
45
0.010
Why?
Arrhythmias, Cardiac
1
2003
317
0.010
Why?
Ventricular Dysfunction, Left
1
2003
385
0.010
Why?
Drug Combinations
1
2000
330
0.010
Why?
Microscopy, Electron
1
1999
426
0.010
Why?
Elasticity
1
1999
196
0.010
Why?
Blood Flow Velocity
1
1999
404
0.010
Why?
Lactic Acid
1
1996
303
0.010
Why?
Regional Blood Flow
1
1996
463
0.010
Why?
Fat Emulsions, Intravenous
1
1994
28
0.010
Why?
Osmolar Concentration
1
1994
166
0.010
Why?
Lactates
1
1994
85
0.010
Why?
Gene Expression Regulation
1
2003
2548
0.010
Why?
NAD
1
1994
75
0.010
Why?
Glycine
1
1994
165
0.010
Why?
Mitochondria, Heart
1
1994
94
0.010
Why?
Oxidative Phosphorylation
1
1994
187
0.010
Why?
Heparin
1
1994
253
0.010
Why?
Cardiac Output, Low
1
1992
66
0.010
Why?
Treatment Outcome
1
2005
10230
0.010
Why?
Greyson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)